Stock listing

Proteomics International Laboratories Ltd.

Selected listing: PIQ · ASX · AUD · AU

Proteomics International Laboratories Ltd. (ASX:PIQ), Health Services. Latest release Sep 14, 2026: PromarkerD and PromarkerEso Commercial Rollout Update.

PIQ:ASXAUDAUUpdated October 2, 2026
Proteomics International Laboratories Ltd. logo
Ticker
ASX:PIQ
Asset type
Stock
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
ASX
Currency
AUD

About Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd. (Ticker: PIQ) is a public company based in Australia, specializing in proteomics and related technologies.

Latest news from Proteomics International Laboratories Ltd.

PromarkerD and PromarkerEso Commercial Rollout Update

September 13, 2026

Appendix 4E and Annual Report

August 31, 2026

Australian patent for PromarkerEndo

August 12, 2026

Proteomics signs national distribution deal with Healius

July 21, 2026

US patent secured for PromarkerEndo

July 7, 2026

All Proteomics International Laboratories Ltd. news →

Research Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd. company profile

View the public company page for Proteomics International Laboratories Ltd. on 6ix.

Proteomics International Laboratories Ltd. news

Read company news and market updates connected to Proteomics International Laboratories Ltd..

Proteomics International Laboratories Ltd. investor events

Find investor webinars, events, and replay context for Proteomics International Laboratories Ltd..

Alternate listings

PIQLF:OTC

US · USD

Alternate listing for Proteomics International Laboratories Ltd.; the primary context on this page is PIQ:ASX.